Drugs Made In America Acquisition Corp. (DMAAR) Other financing activities (2025)

Drugs Made In America Acquisition (DMAAR) has reported Other financing activities for 1 consecutive years, with $3.2 million the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Other financing activities changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (changed N/A YoY), and the FY2025 full-year result was $3.2 million, changed N/A from the prior year.
• Other financing activities held at $3.2 million in Q1 2025 per DMAAR's latest filing.
• Across five years, Other financing activities topped out at $3.2 million in Q1 2025 and bottomed at $3.2 million in Q1 2025.